Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic
- PMID: 20534730
- PMCID: PMC2964781
- DOI: 10.1210/en.2010-0101
Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic
Abstract
We have examined the effects of acute administration of the cannabinoid receptor type 1 (CB(1)) antagonist AM251 on the rat hypothalamic-pituitary-adrenal (HPA) axis with respect to both gender and time of day. Blood samples were collected from conscious male and female rats every 5 min using an automated blood sampling system, and corticosterone concentrations were determined. In male rats, there was a distinct diurnal effect of AM251 with a greater activation of the HPA axis in the morning (diurnal trough) compared with the evening (diurnal peak). At both times of the day, circulating corticosterone concentrations were elevated for approximately 4 h after AM251 administration. In female rats, there was also diurnal variation in the activation of the HPA axis; however, these effects were not as profound as those in males. Corticosterone concentrations were only slightly elevated at the diurnal trough and for a shorter time period than in males (2 compared with 4 h). Moreover, there was no effect of AM251 on corticosterone concentrations when administered at the diurnal peak. Subsequent studies, only in males, in which both ACTH and corticosterone were measured, confirmed that the effects of AM251 on corticosterone were mediated by ACTH. Moreover, the elevation of both ACTH and corticosterone could be replicated using another CB(1) antagonist, AM281. These data demonstrate that the extent and duration of HPA axis activation after CB(1) blockade are clearly dependent on both gender and time of day.
Figures




Similar articles
-
Cannabinoid receptor type 1 antagonism significantly modulates basal and loud noise induced neural and hypothalamic-pituitary-adrenal axis responses in male Sprague-Dawley rats.Neuroscience. 2012 Mar 1;204:64-73. doi: 10.1016/j.neuroscience.2011.11.043. Epub 2011 Nov 28. Neuroscience. 2012. PMID: 22138156 Free PMC article.
-
Rapid alteration of stress-induced hypothalamic-pituitary-adrenal hormone secretion in the rat: a comparison of glucocorticoids and cannabinoids.Stress. 2010 May;13(3):248-57. doi: 10.3109/10253890903336839. Stress. 2010. PMID: 20392196
-
Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis.Neuropsychopharmacology. 2009 Dec;34(13):2733-45. doi: 10.1038/npp.2009.114. Epub 2009 Aug 26. Neuropsychopharmacology. 2009. PMID: 19710634 Free PMC article.
-
A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist.J Neurosci. 1996 Sep 1;16(17):5555-65. doi: 10.1523/JNEUROSCI.16-17-05555.1996. J Neurosci. 1996. PMID: 8757267 Free PMC article. Review.
-
The importance of the circadian trough in glucocorticoid signaling: a variation on B-flat.Stress. 2023 Nov;26(1):2275210. doi: 10.1080/10253890.2023.2275210. Epub 2023 Oct 30. Stress. 2023. PMID: 37874158 Review.
Cited by
-
Uncoupling genotoxic stress responses from circadian control increases susceptibility to mammary carcinogenesis.Oncotarget. 2017 May 16;8(20):32752-32768. doi: 10.18632/oncotarget.15678. Oncotarget. 2017. PMID: 28427145 Free PMC article.
-
Replication and expansion of "Best Practice Guide for the Treatment of Nightmare Disorder in Adults".J Clin Sleep Med. 2011 Oct 15;7(5):549-53; discussion 554-6. doi: 10.5664/JCSM.1330. J Clin Sleep Med. 2011. PMID: 22003352 Free PMC article.
-
Sex differences in the effect of cannabinoid type 1 receptor deletion on locus coeruleus-norepinephrine neurons and corticotropin releasing factor-mediated responses.Eur J Neurosci. 2018 Sep;48(5):2118-2138. doi: 10.1111/ejn.14103. Eur J Neurosci. 2018. PMID: 30103253 Free PMC article.
-
Endocannabinoids and the Endocrine System in Health and Disease.Handb Exp Pharmacol. 2015;231:317-39. doi: 10.1007/978-3-319-20825-1_11. Handb Exp Pharmacol. 2015. PMID: 26408166 Free PMC article. Review.
-
Endocannabinoid Signaling in Autism.Neurotherapeutics. 2015 Oct;12(4):837-47. doi: 10.1007/s13311-015-0371-9. Neurotherapeutics. 2015. PMID: 26216231 Free PMC article. Review.
References
-
- Dallman MF, Yates FE 1969 Dynamic asymmetries in the corticosteroid feedback path and distribution-metabolism-binding elements of the adrenocortical system. Ann NY Acad Sci 156:696–721 - PubMed
-
- Lightman SL, Windle RJ, Julian MD, Harbuz MS, Shanks N, Wood SA, Kershaw YM, Ingram CD 2000 Significance of pulsatility in the HPA axis. Novartis Found Symp 227:244–257; discussion 257–260 - PubMed
-
- Chrousos GP 1998 Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity: a dynamic digital-to-analog modulation. Endocrinology 139:437–440 - PubMed
-
- Hastings M, O'Neill JS, Maywood ES 2007 Circadian clocks: regulators of endocrine and metabolic rhythms. J Endocrinol 195:187–198 - PubMed
-
- Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, Schütz G, Schibler U 2000 Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289:2344–2347 - PubMed